NCT02444936View on ClinicalTrials.gov

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

PHASE4UnknownINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions

Shingles

Interventions

DRUG

ZOSTAVAX

Shingles vaccine

Sponsors

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Duke University

OTHER

lead

Louis Stokes VA Medical Center

FED